Neurochem Down for the Count?
12314
Its Alzheimer's treatment flops in testing, on the heels of FDA disapproval of another Neurochem drug.
98759
By Marc Silvestrini, Waterbury Republican-American, Conn.  Feb. 13--Chemtura Corp. on Monday reported a wider net loss for the  fourth quarter, but a narrower loss for the fiscal year.
239946
The spate of bad news about painkillers has dealt a major setback to what had been a highly promising effort to use the drugs to prevent a host of leading killers, including many types of cancer, Alzheimer&#39;s and other forms of dementia.
343807
The EU Commission could fine Microsoft up to 5 percent of its daily turnover if things don't change. Also: Ford recalls almost 800,000 cars that spontaneously burst into flames & hellip;.  The money is rolling in on cell sales & hellip;. and more.
200597
Tycho:  He came into work yesterday with a prescription for something that will alter his brain chemistry, which I thought was a big step for the man who refuses to take aspirin.  We've long canonized our respective lunacies, believing it is like some artistic sacrament that makes our bizarre endeavor possible.  We have relied upon them.  Or, at any rate, we did.
140996
A day late and possibly several millions of dollars short. That's the scenario facing one drug manufacturer unless it can get a helping hand from Congress.
722145
Will Pfizer be able to offset the looming loss of Lipitor?
271921
The reduction in patients for Amylin's Byetta diabetes drug could be small.
451154
A drug approved last year as a last-ditch hope for some lung cancer patients who didn&#39;t find relief from other forms of therapy has come up short in a large clinical trial.
176876
Drugs given to patients with multiple sclerosis can reduce brain tissue loss and slow down the progression of the illness, scientists said on Friday.
111465
TUESDAY, Aug. 24 (HealthDayNews) -- Reducing levels of specific toxins in the brain may help stabilize cognitive decline in Alzheimer's disease patients.
204544
Will Genzyme's Campath get approval?
710590
NEW YORK  - Chemotherapy causes transient changes in sensitive areas of the brain, which may partly account for some of the previously reported cognitive difficulties reported by patients and referred to as "chemobrain," Japanese investigators report in the journal Cancer.
232794
By Tampone, Kevin  CICERO - Cancer research is daunting for a variety of reasons, not the least of which is the massive number of substances that might be effective in future drugs.
10518
About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency&#39;s monitoring of the safety of prescription
237585
Drug therapy given before the  primary chemotherapy for breast cancer does not appear to  worsen mental processes, or &quot;cognitive function,&quot; German  investigators report in the journal Cancer. Suspicions that it  does may have been influenced by cases of mental decline that  occurred before treatment began.
189691
Elson So, MD, of the Mayo Clinic in Rochester, Minn., and colleagues report their findings in the Nov. 9 issue of the journal Neurology.